Weekly Recap | GENSCRIPT BIO -3%, consensus target above spotWeekly Review·Nov 14, 2026 at 05:08 AM01548-3.76%
JPM: GENSCRIPT BIO US New Nucleic Acid Screening Rules a Manageable IssueAASTOCKS News·Nov 10, 2026 at 06:00 AM01548-3.76%
M Stanley: China AI Drug R&D Financing Accelerates, GENSCRIPT BIO Benefits from Wet Lab DemandAASTOCKS News·Nov 9, 2026 at 09:20 AM01548-3.76%
Weekly Recap | GENSCRIPT BIO -15.04%, consensus target above spotWeekly Review·Nov 7, 2026 at 05:33 AM01548-3.76%
Huatai Raises GENSCRIPT B-1K Earnings Forecasts on AIDD Benefits, Reiterates BuyAASTOCKS News·Nov 5, 2026 at 03:53 AM01548-3.76%
Legend Biotech to Present Cell-Therapy Data at ASH 2026Tip Ranks·Nov 4, 2026 at 11:42 PMLEGN+0.87%01548-3.76%